TherapeuticsMD (TXMD) Capital Expenditures Growth (1y) (2012 - 2023)
TherapeuticsMD (TXMD) Capital Expenditures Growth (1y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.24 Bn | 87.37 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.17 Bn | 1.97 Bn | 32.28% |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn | -38.20% |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | -15.72% |
| 5 | United Therapeutics | 23.28 Bn | 21.13 Bn | 648.10 Mn | 32.98% |
| 6 | RedHill Biopharma | 20.54 Bn | 20.54 Bn | - | - |
| 7 | Viatris | 20.31 Bn | 18.50 Bn | 1.16 Bn | -6.34% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -86.92% |
| 9 | Elanco Animal Health | 12.55 Bn | 12.12 Bn | 785.00 Mn | -21.54% |
| 10 | TherapeuticsMD | 281,519.99 | -8.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -69.65% |
| Jun 30, 2023 | -2,200.00% |
| Mar 31, 2023 | -54.76% |
| Jun 30, 2022 | -151.22% |
| Mar 31, 2022 | -33.33% |
| Sep 30, 2021 | -638.46% |
| Jun 30, 2021 | 720.00% |
| Mar 31, 2021 | 200.00% |
| Dec 31, 2020 | -53.41% |
| Sep 30, 2020 | -98.70% |
| Jun 30, 2020 | -99.40% |
| Mar 31, 2020 | -92.00% |
| Dec 31, 2019 | 139.20% |
| Sep 30, 2019 | 4,745.24% |
| Jun 30, 2019 | 4,312.53% |
| Mar 31, 2019 | 875.24% |
| Dec 31, 2018 | 480.50% |
| Jun 30, 2018 | 134.71% |
| Mar 31, 2018 | -3.33% |
| Dec 31, 2017 | -70.64% |